← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


Do you know where your DMPK labs are? All QPS DMPK studies are done in the USA!  This month, discover more about our wide variety of DMPK research capabilities, review our ultimate guide to oligonucleotides, and catch up on the latest breakthroughs and insights on the QPS blog.

New Guidance Forcing a Change?

QPS DMPK Labs are "Made in the USA"!

All QPS DMPK studies are conducted in our laboratories in Newark, Delaware, USA.


Our DMPK expertise encompasses the entire preclinical drug development process, from discovery and candidate selection to investigational new drug (IND) enabling studies. 


Studies that assess the absorption, distribution, metabolism, and excretion (ADME) properties of drug candidates are a fundamental component of the drug metabolism and pharmacokinetics (DMPK) services offered by QPS. 

Contact QPS About Our DMPK Services

What Is Oligonucleotide Drug Development?

QPS has supported gene therapy development since 2002 and can use that experience to help you navigate PK, ADME, immunogenicity, viral clearance, and biodistribution of these novel molecules in this rapidly expanding field.


QPS scientists are ready to work with you to determine specific study parameters and provide complete, fully compliant data packages and reports, ready for submission.

Discover the Future of Science on the QPS Blog

A Double-Edged Cure: Antibiotics Linked to Childhood Asthma and Allergies


Antibiotics, revered as critical defenders against bacterial infections, might harbor an unexpected threat, particularly to very young children. New findings published in the Journal of Infectious Diseases show...


Antibiotics and the Fragile Microbiome

More Drug Development Blog Posts

Chew on This: How Chewing Gum Could Fight the Flu


Cold and flu medicine likely isn’t your idea of a tasty treat. But what if tackling the flu was as easy as chewing a piece of gum? Scientists have developed an antiviral chewing gum that can safely trap the influenza virus, as well as the virus that causes the


Antiviral Gum?

Explore the QPS Blog

Visit our website www.qps.com 

or contact us at info@qps.com

to start your next study.

Linkedin  Youtube  Twitter  Facebook  

www.qps.cominfo@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive